Work

Phase I study of PM00104, a novel cytotoxic anti-cancer drug, administered to patients with advanced solid tumors or lymphoma

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.2517

Authors: E. Gallerani, T. A. Yap, A. Lopez, C. Coronado, H. Shaw, A. Florez, B. de las Heras, H. Cortes-Funes, J. de Bono, L. Paz-Ares

Institutions: Hospital Universitario 12 De Octubre, Royal Marsden Hospital

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2922057975

Cites:

Cited by: 1

Related to: 10